http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-24112-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
filingDate 1995-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a97dfe2f4181d71ddf3344968bdfc55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf85debc01bedae7f9b88a2798ebee38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc25487834323a451dc6f1016c0c122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74c9daac8da3c731cb6f4a546cb59f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d475f82400f2678822cfeeb0bffec745
publicationDate 1996-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UY-24112-A1
titleOfInvention PROCESS TO PURIFY SURFACE VIRAL ANTIGEN FROM HEPATITIS B INCLUDING PRES 2 PEPTIDE
abstract A method for purifying hepatitis B viral surface antigen comprising the pres 2 peptide from the cells of a recombinant organism, characterized in that it causes the disruption of the mentioned cells using a buffer containing a chaotropic salt. This process to purify comprises a reconbinant organism comprising the steps of: breaking down cells; add a surfactant; increase solubility, precipitate and remove contaminating challenges, lipids and proteins from the cell; acidifying and then centrifuging the extract; contact the solution obtained after precipitating, with silica, to absorb the antigent from the surface on the silica, washing the contaminating proteins and desorbing the antigen from the surface, starting from the silica, using a neutralizer, in a pH range of 6 to 8 to obtain a fraction of the purified surface antigen.
priorityDate 1994-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261

Total number of triples: 31.